Creative Planning’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$285K Sell
2,741
-65
-2% -$6.92K ﹤0.01% 3467
2025
Q4
$289K Buy
+2,806
New +$273K ﹤0.01% 3268
2018
Q1
Sell
-11,900
Closed -$706K 2100
2017
Q4
$706K Buy
+11,900
New +$682K ﹤0.01% 888
2017
Q3
Sell
-2,360
Closed -$139K 3235
2017
Q2
$139K Hold
2,360
﹤0.01% 1750
2017
Q1
$130K Sell
2,360
-17,290
-88% -$938K ﹤0.01% 1783
2016
Q4
$1.03M Buy
19,650
+16,000
+438% +$855K 0.01% 611
2016
Q3
$210K Hold
3,650
﹤0.01% 1377
2016
Q2
$214K Sell
3,650
-6,000
-62% -$350K ﹤0.01% 1226
2016
Q1
$555K Buy
9,650
+6,200
+180% +$367K ﹤0.01% 711
2015
Q4
$225K Sell
3,450
-3,654
-51% -$236K ﹤0.01% 1136
2015
Q3
$447K Sell
7,104
-7,896
-53% -$555K ﹤0.01% 785
2015
Q2
$1.06M Buy
15,000
+12,000
+400% +$864K 0.01% 451
2015
Q1
$211K Sell
3,000
-3,950
-57% -$268K ﹤0.01% 1170
2014
Q4
$447K Buy
6,950
+6,920
+23,067% +$441K ﹤0.01% 747
2014
Q3
$2K Buy
+30
New +$1.86K ﹤0.01% 3683
2013
Q4
Sell
-200
Closed -$10K 3434
2013
Q3
$10K Buy
+200
New +$9.48K ﹤0.01% 2468

Other funds holding PPH

Creative Planning's PPH Position: Q1 2026 in Review

Creative Planning reduced its VanEck Pharmaceutical ETF (PPH) stake by 2.3% in Q1 2026, selling an estimated $6.92K and leaving 2,741 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #3467.

Creative Planning first reported a position in PPH in Q3 2013 and has held it in 16 quarters since. The position peaked at $1.06M in Q2 2015. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Creative Planning held 2,741 shares of VanEck Pharmaceutical ETF worth $285K as of Q1 2026.
  • Creative Planning sold 65 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $6.92K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3467 holding.
  • Creative Planning first reported a position in VanEck Pharmaceutical ETF in Q3 2013 and has held it in 16 quarters since.
  • Creative Planning's VanEck Pharmaceutical ETF position peaked at $1.06M in Q2 2015.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.